| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate |
1999-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2002-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002519364-A |
| titleOfInvention |
Vascular embolization-forming composition containing ethyl lactate and method of using the same |
| abstract |
(57) [Summary]nPROBLEM TO BE SOLVED: To provide a completely biocompatible vasoemboli-forming solvent which can impart sufficient polymer solubility to a vasoembolic composition without generating undesirable side effects.nSOLUTION: Ethyl lactate is used as a vasoembolic solvent. |
| priorityDate |
1998-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |